Róbert Sepp

3.6k total citations
54 papers, 722 citations indexed

About

Róbert Sepp is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Róbert Sepp has authored 54 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cardiology and Cardiovascular Medicine, 13 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Róbert Sepp's work include Cardiomyopathy and Myosin Studies (20 papers), Cardiovascular Function and Risk Factors (13 papers) and Cardiovascular Effects of Exercise (12 papers). Róbert Sepp is often cited by papers focused on Cardiomyopathy and Myosin Studies (20 papers), Cardiovascular Function and Risk Factors (13 papers) and Cardiovascular Effects of Exercise (12 papers). Róbert Sepp collaborates with scholars based in Hungary, Spain and Japan. Róbert Sepp's co-authors include Nicholas J. Severs, Robert G. Gourdie, Hirotsugu Uda, Ildikò Szabó, H. Sakamoto, Tamás Forster, Miklós Csanády, Attila Nemes, Yvette Mándi and Krisztina Buzás and has published in prestigious journals such as PLoS ONE, Cancer and European Heart Journal.

In The Last Decade

Róbert Sepp

52 papers receiving 699 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Róbert Sepp Hungary 14 386 262 113 88 67 54 722
Sirui Yang China 14 190 0.5× 140 0.5× 57 0.5× 113 1.3× 67 1.0× 37 761
Shaohui Wu China 14 338 0.9× 170 0.6× 62 0.5× 86 1.0× 45 0.7× 48 611
Eri Watanabe Japan 15 190 0.5× 102 0.4× 66 0.6× 110 1.3× 42 0.6× 49 731
Ulrich Schweigmann Austria 11 251 0.7× 295 1.1× 112 1.0× 176 2.0× 125 1.9× 24 717
Marco Baron Toaldo Italy 14 256 0.7× 172 0.7× 137 1.2× 83 0.9× 129 1.9× 76 747
Yasutomo Hori Japan 17 338 0.9× 127 0.5× 104 0.9× 85 1.0× 162 2.4× 80 825
Donna Smith United States 13 158 0.4× 165 0.6× 38 0.3× 250 2.8× 78 1.2× 21 1.0k
Deborah M. Fine United States 16 362 0.9× 240 0.9× 125 1.1× 122 1.4× 108 1.6× 33 862
James Bradley United States 13 225 0.6× 195 0.7× 254 2.2× 329 3.7× 17 0.3× 33 830
María Josefa Fernández del Palacio Spain 14 117 0.3× 72 0.3× 73 0.6× 81 0.9× 96 1.4× 39 481

Countries citing papers authored by Róbert Sepp

Since Specialization
Citations

This map shows the geographic impact of Róbert Sepp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Róbert Sepp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Róbert Sepp more than expected).

Fields of papers citing papers by Róbert Sepp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Róbert Sepp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Róbert Sepp. The network helps show where Róbert Sepp may publish in the future.

Co-authorship network of co-authors of Róbert Sepp

This figure shows the co-authorship network connecting the top 25 collaborators of Róbert Sepp. A scholar is included among the top collaborators of Róbert Sepp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Róbert Sepp. Róbert Sepp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rácz, Gergely, Krisztina Boda, Attila Pálinkás, et al.. (2025). Mavacamten effectively reduces > 100 mmHg left ventricular outflow tract gradients as early as one week of treatment in obstructive hypertrophic cardiomyopathy. International Journal of Cardiology. 442. 133882–133882.
2.
Vereckei, András, et al.. (2024). Novel Electrocardiographic Criteria May Render Possible the More Accurate Recognition of Cardiac Amyloidosis. ESC Heart Failure. 11(2). 1030–1038. 3 indexed citations
3.
Perotto, Maria, Róbert Sepp, S. K. Prasad, et al.. (2023). Genetic and phenotypic characterization of Nexilin (NEXN) related cardiomyopathy. European Heart Journal. 44(Supplement_2). 1 indexed citations
4.
Sepp, Róbert, et al.. (2023). Incidence and Predictors of Heart Failure with Improved Ejection Fraction Category in a HFrEF Patient Population. ESC Heart Failure. 11(2). 783–794. 8 indexed citations
5.
Révész, Katalin, Gergely Varga, Péter Farkas, et al.. (2022). Cardiac Amyloidosis with Normal Wall Thickness: Prevalence, Clinical Characteristics and Outcome in a Retrospective Analysis. Biomedicines. 10(7). 1765–1765. 9 indexed citations
6.
Re, Federica, Jesús Peteiro, Milorad Tešić, et al.. (2022). Pulmonary congestion during Exercise stress Echocardiography in Hypertrophic Cardiomyopathy. The International Journal of Cardiovascular Imaging. 38(12). 2593–2604. 7 indexed citations
7.
Vámos, Máté, Lidia Haţegan, Lilla Hanák, et al.. (2022). Geno- and phenotypic characteristics and clinical outcomes of CACNA1C gene mutation associated Timothy syndrome, “cardiac only” Timothy syndrome and isolated long QT syndrome 8: A systematic review. Frontiers in Cardiovascular Medicine. 9. 1021009–1021009. 5 indexed citations
8.
Vereckei, András, Gábor Katona, Katalin Révész, et al.. (2022). Cardiac Sarcoidosis Completely Mimicking Biventricular Arrhythmogenic Cardiomyopathy. ESC Heart Failure. 9(6). 4304–4314. 3 indexed citations
9.
Mátrai, Péter, Péter Hegyi, Dávid Németh, et al.. (2022). Noninvasive ventilation improves the outcome in patients with pneumonia-associated respiratory failure: Systematic review and meta-analysis. Journal of Infection and Public Health. 15(3). 349–359. 12 indexed citations
10.
Haţegan, Lidia, Balázs Ördög, Orsolya Kiss, et al.. (2017). A novel ‘splice site’ HCN4 Gene mutation, c.1737 + 1 G > T, causes familial bradycardia, reduced heart rate response, impaired chronotropic competence and increased short-term heart rate variability. International Journal of Cardiology. 241. 364–372. 11 indexed citations
11.
Haţegan, Lidia, Zoltán Hegedüs, László Sághy, et al.. (2016). Identification of Two Novel LAMP2 Gene Mutations in Danon Disease. Canadian Journal of Cardiology. 32(11). 1355.e23–1355.e30. 12 indexed citations
12.
Pap, Róbert, Róbert Sepp, & László Sághy. (2015). Termination of Persistent Perimitral Atrial Flutter by Selective Contrast Injection Into the Vein of Marshall. JACC. Clinical electrophysiology. 1(6). 596–597. 2 indexed citations
13.
Nemes, Attila, et al.. (2012). Videodensitometric time-density curve change after alcohol septal ablation of obstructive hypertrophic cardiomyopathy. Netherlands Heart Journal. 23(2). 143–144. 1 indexed citations
14.
15.
Ruzsa, Zoltán, Imre Ungi, Róbert Sepp, et al.. (2009). Five-year experience with transradial coronary angioplasty in ST-segment-elevation myocardial infarction. Cardiovascular revascularization medicine. 10(2). 73–79. 16 indexed citations
16.
17.
Csanády, Miklós, Ferenc Tóth, Róbert Sepp, et al.. (2006). Hearing disturbances in hypertrophic cardiomyopathy. Is the sensorineural disorder neurogenic or myogenic?. International Journal of Cardiology. 116(1). 53–56. 1 indexed citations
18.
Csanády, Miklós & Róbert Sepp. (2005). [The long QT syndrome from the bedside to molecular genetic laboratory. The history of the first described Hungarian family].. PubMed. 146(39). 2011–6.
19.
Mándi, Yvette, et al.. (2004). Comparison of circulating levels of interleukin-6 and tumor necrosis factor-alpha in hypertrophic cardiomyopathy and in idiopathic dilated cardiomyopathy. The American Journal of Cardiology. 94(2). 249–251. 63 indexed citations
20.
Kuwabara, Hiroko, et al.. (1993). Nucleolar organizer regions in human maxillary sinus squamous cell carcinoma. Acta Pathologica Japonica. 43(1-2). 18–21. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sirui Yang Breakdown of academic impact, for papers by Shaohui Wu Breakdown of academic impact, for papers by Eri Watanabe Breakdown of academic impact, for papers by Ulrich Schweigmann Breakdown of academic impact, for papers by Marco Baron Toaldo Breakdown of academic impact, for papers by Yasutomo Hori Breakdown of academic impact, for papers by Donna Smith Breakdown of academic impact, for papers by Deborah M. Fine Breakdown of academic impact, for papers by James Bradley Breakdown of academic impact, for papers by María Josefa Fernández del Palacio
Rankless by CCL
2026